UMIN-CTR Clinical Trial

Recruitment status No longer recruiting
Unique ID issued by UMIN UMIN000021009
Receipt No. R000024247
Official scientific title of the study Direct peroral cholangioscopic diagnosis of bile duct lesions by high definition ultraslim endoscopy combined with computed virtual chromoendoscopy using i-scan; a pilot study (with videos)
Date of disclosure of the study information 2016/02/14
Last modified on 2016/04/23 (Ver. 2)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Direct peroral cholangioscopic diagnosis of bile duct lesions by high definition ultraslim endoscopy combined with computed virtual chromoendoscopy using i-scan; a pilot study (with videos)
Title of the study (Brief title) computed virtual chromoendoscopy using i-scan versus white light in the evaluation of biliary tract lesions
Region
Asia(except Japan)

Condition
Condition biliary polypoid and elevated lesions
Classification by specialty
Gastroenterology
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 To evaluate the efficacy of direct POC alone and in conjunction with NBIori-scan for the diagnosis of biliary polypoid and elevated lesions.
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Diagnostic efficacy of direct POC with NBI or i-scan in biliary polypoid and elevated lesions.
Key secondary outcomes

In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field.

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Non-randomized
Randomization unit
Blinding Single blind -participants are blinded
Control Active
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 2
Purpose of intervention Diagnosis
Type of intervention
Device,equipment
Interventions/Control_1 DPOC with NBI
Interventions/Control_2 DPOC with i-scan
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required.

Eligibility
Age-lower limit
18 years-old <
Age-upper limit
90 years-old >=
Gender Male and Female
Key inclusion criteria 1. Intraductal bile duct mucosal lesion
2. Bile duct diameter >8mm
3. A previous sphincteroplasty
such as major endoscopic sphincterotomy and/or endoscopic
papillary balloon dilatation during a prior ERCP.
Key exclusion criteria 1. a bleeding tendency (international
normalized ratio >1.5 or platelet count <50,000/mm3)
2. diffuse stricture of the distal CBD, evidence of pancreatic cancer or tumor at the ampulla of Vater
3. contraindications for endoscopic retrograde cholangiography
Target sample size 25

Research contact person
Name of lead principal investigator Jong Ho Moon
Organization SoonChunHyang University
School of Medicine
Division name Digestive Disease Center and Research Institute, Department of Internal Medicine
Address Digestive Disease Center and Research Institute, SoonChunHyang University Bucheon Hospital, 170 Jomaru-ro, Wonmi-gu, Bucheon 420-767, Korea
TEL +82-32-621-5094
Email jhmoon@schmc.ac.kr

Public contact
Name of contact person Yun Nah Lee
Organization Department of Internal Medicine, Soon Chun Hyang University School of Medicine
Division name Digestive Disease Center and Research Institute, Department of Internal Medicine
Address Digestive Disease Center and Research Institute, SoonChunHyang University Bucheon Hospital, 170 Joma
TEL +82-32-621-5094
Homepage URL
Email yunnah@schmc.ac.kr

Sponsor
Institute SoonChunHyang University
Institute
Department

Sponsor means an organization that is responsible for plan, deployment and
report of the research including funding management. It doesn't mean
funding agency". Therefore, all clinical trial should have the one.

Funding Source
Organization SoonChunHyang University
Organization
Division
Category of Funding Organization Non profit foundation
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2016 Year 02 Month 14 Day

Progress
Recruitment status No longer recruiting
Date of protocol fixation
2009 Year 09 Month 10 Day
Anticipated trial start date
2009 Year 09 Month 20 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2016 Year 02 Month 13 Day
Last modified on
2016 Year 04 Month 23 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000024247